Evidence map›Paper›PMID 21196354›Full record

ReviewFrontiers in bioscience (Scholar edition)2011

Myelin, copper, and the cuprizone model of schizophrenia.

Nicole R Herring, Christine Konradi

Open access · bronzeAbstract readReview
In one paragraph

Review in Frontiers in bioscience (Scholar edition), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Potential of Hair Matrix for Biomarker Analysis in Schizophrenia.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Cognitive and anti-inflammatory effects ofFrontiers in neuroscience · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nicole R HerringDepartment of Pharmacology, Center for Molecular Neuroscience and Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, Tennessee 37203, USA.
Christine Konradi
Vanderbilt University · US

Funding

Inst.Research and Academic Career Development AwardK12GM068543 · NIGMS · VANDERBILT UNIVERSITY · PI CHALKLEY, G. ROGER · 2003 to 2009
$1.6M
Hippocampus in Schizophrenia and Bipolar DisorderR01MH067999 · NIMH · VANDERBILT UNIVERSITY · PI HECKERS, STEPHAN · 2004 to 2008
$1.2M
Antipsychotic drug effects in limbic structuresR01MH074000 · NIMH · VANDERBILT UNIVERSITY · PI KONRADI, CHRISTINE L · 2006 to 2008
$878k
NIGMS NIH HHS K12 GM068543NIGMS NIH HHS K12GM068543NIMH NIH HHS MH74000NIMH NIH HHS R01 MH067999NIMH NIH HHS R01 MH074000
6 · The paper itself

Abstract

In recent years increasing evidence is pointing toward white matter abnormalities in schizophrenia and other psychiatric disorders. The present paper will provide an overview over the role of myelin in cognition and brain function, and its potential involvement in brain disorders. Furthermore, we will examine one particular experimental model for the study of dysmyelination, created by the administration of the toxin cuprizone. Cuprizone, a copper chelator, causes white matter abnormalities in rodents. The administration of cuprizone during specific developmental periods allows for the targeting of specific brain areas for dysmyelination. Thus, cuprizone can be used to study the pathogenesis and pathophysiology of myelin deficiencies in the central nervous system, and its effect on behaviors relevant to psychiatric disorders.

Indexed as

Biological EvolutionAnimalsCopperCuprizoneDemyelinating DiseasesDisease Models, AnimalHumansMiceMyelin SheathOligodendrogliaSchizophreniaCopperCuprizone

Identifiers

PMID21196354
PMCPMC3058516
OpenAlexW108090138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.